Cancer Clinical Trial
Official title:
Cancer Survivorship Issues: A Survey of Patients in India.AIIMS Study (CANSURVIVE)
The purpose of this study is to assess the various aspects of life in the cancer survivors
in India. Cancer survivor is defined as "an individual diagnosed with cancer and who has
survived the disease and treatment, and for the rest of his/her life".
Cancer survivors are at increased risk of developing various physical and psychosocial
conditions, which require to be identified and attended within the cancer care system.
Survivorship research is seen as addressing the medical, functional, and health related
issues of individuals diagnosed with cancer, as well as that of their families.
It is estimated that approximately 25 million people are living as cancer survivors
worldwide. The cancer survivors are those individuals who live beyond a cancer diagnosis and
its therapy. Within the existing health care system, the cancer care models are largely
focused on diagnostic methods, treatment aspects, cure, and disease failure and survival
rates. There is very little research and intervention approaches for the after-effects of
cancer diagnosis and treatments for an individual cancer patient. Cancer survivors are at
increased risk of developing various physical and psychosocial conditions, which require to
be identified and attended within the cancer care system. In the developing countries like
India, the cancer cure rates are improving due to improvements in comprehensive diagnostic
and treatment strategies. Cancer survivorship research will be valuable to enhance our
understanding and care approaches to these vulnerable individuals in our society. There is
lack of evaluation tools which can completely fit to assess all issues such as physical,
social, financial, mental aspects of a cancer survivor.
Hence the investigators of this observational study have prepared an empirical cancer
survivorship questionnaire (CSQ) which will document the patient's disease and treatment
details and obtain subjective responses from the patient(and/or family care giver) related
to the physical, functional, social, economic and mental aspects of daily living of a cancer
survivor. In order to assess the mental status of the survivors, the investigators have also
included the widely used and internationally accepted MINI (Mini-international
neuropsychiatry interview) version along with the CSQ in this survey. Researchers and
clinicians working in non-profit and academic setting such as this institution are allowed
to make copies of this MINI questionnaire for the purpose of clinical and research use. For
the present study, MINI version is suitably modified to exclude the items which are already
in the CSQ, and certain items are reframed for the socio-cultural requirement. Both the CSQ
(45 items) and MINI-modified (13 items) will be applied simultaneously in this survey as a
direct face to face response documentation from the patient (cancer survivor), along with
his/her family member. Patients will be chosen for this cross-sectional survey during the
follow-up visit to a cancer clinic of this hospital, at least 3 months after the completion
of cancer diagnosis and therapy. Each participant is expected to complete the survey at the
first encounter, however, a provision is made to report any missing information at later
visit.
An interim analysis will be carried out after the survey of first 50 patients to observe the
trends in the findings. However, this will not impact the further accrual, except for making
some changes in the survey parameters if at all needed.
;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|